aluates Reports

$ 0.0

Automative

Global Assisted Reproductive Technologies Drugs Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-9K13188

Global Assisted Reproductive Technologies Drugs Market Research Report 2023

BUY CHAPTERS

Global Assisted Reproductive Technologies Drugs Market Research Report 2025

Code: QYRE-Auto-9K13188

Report

May 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ipsen S A

Ferring

Organon

Solvay S A

Zhejiang Xianju

Hybio Pharmaceutical

Livzon Pharmaceutical

Besins

Changchun GeneScience

Merck Serono

Assisted Reproductive Technologies Drugs Market Size

The global market for Assisted Reproductive Technologies Drugs was valued at US$ 13300 million in the year 2024 and is projected to reach a revised size of US$ 20550 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Assisted Reproductive Technologies Drugs Market

Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Technologies Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Technologies Drugs.

The Assisted Reproductive Technologies Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Assisted Reproductive Technologies Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Assisted Reproductive Technologies Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Assisted Reproductive Technologies Drugs Market Report

Report Metric	Details
Report Name	Assisted Reproductive Technologies Drugs Market
Accounted market size in year	US$ 13300 million
Forecasted market size in 2031	US$ 20550 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Down-Regulation Drugs Ovulation Stimulation Drugs Ovulation Inducing Drugs Luteal Support Medications
Segment by Application	Hospital Pharmacy Specialty & Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck Serono, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju, Changchun GeneScience, Hybio Pharmaceutical, Livzon Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Assisted Reproductive Technologies Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Assisted Reproductive Technologies Drugs Market growing?

Ans: The Assisted Reproductive Technologies Drugs Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Assisted Reproductive Technologies Drugs Market size in 2031?

Ans: The Assisted Reproductive Technologies Drugs Market size in 2031 will be US$ 20550 million.

Who are the main players in the Assisted Reproductive Technologies Drugs Market report?

Ans: The main players in the Assisted Reproductive Technologies Drugs Market are Merck Serono, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju, Changchun GeneScience, Hybio Pharmaceutical, Livzon Pharmaceutical

What are the Application segmentation covered in the Assisted Reproductive Technologies Drugs Market report?

Ans: The Applications covered in the Assisted Reproductive Technologies Drugs Market report are Hospital Pharmacy, Specialty & Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Assisted Reproductive Technologies Drugs Market report?

Ans: The Types covered in the Assisted Reproductive Technologies Drugs Market report are Down-Regulation Drugs, Ovulation Stimulation Drugs, Ovulation Inducing Drugs, Luteal Support Medications

Recommended Reports

Reproductive & Gynecology

Hormonal & Menopause

Genitourinary & Cancer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Assisted Reproductive Technologies Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Down-Regulation Drugs

1.2.3 Ovulation Stimulation Drugs

1.2.4 Ovulation Inducing Drugs

1.2.5 Luteal Support Medications

1.3 Market by Application

1.3.1 Global Assisted Reproductive Technologies Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Specialty & Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Assisted Reproductive Technologies Drugs Market Perspective (2020-2031)

2.2 Global Assisted Reproductive Technologies Drugs Growth Trends by Region

2.2.1 Global Assisted Reproductive Technologies Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Assisted Reproductive Technologies Drugs Historic Market Size by Region (2020-2025)

2.2.3 Assisted Reproductive Technologies Drugs Forecasted Market Size by Region (2026-2031)

2.3 Assisted Reproductive Technologies Drugs Market Dynamics

2.3.1 Assisted Reproductive Technologies Drugs Industry Trends

2.3.2 Assisted Reproductive Technologies Drugs Market Drivers

2.3.3 Assisted Reproductive Technologies Drugs Market Challenges

2.3.4 Assisted Reproductive Technologies Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Assisted Reproductive Technologies Drugs Players by Revenue

3.1.1 Global Top Assisted Reproductive Technologies Drugs Players by Revenue (2020-2025)

3.1.2 Global Assisted Reproductive Technologies Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Assisted Reproductive Technologies Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Assisted Reproductive Technologies Drugs Revenue

3.4 Global Assisted Reproductive Technologies Drugs Market Concentration Ratio

3.4.1 Global Assisted Reproductive Technologies Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Assisted Reproductive Technologies Drugs Revenue in 2024

3.5 Global Key Players of Assisted Reproductive Technologies Drugs Head office and Area Served

3.6 Global Key Players of Assisted Reproductive Technologies Drugs, Product and Application

3.7 Global Key Players of Assisted Reproductive Technologies Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Assisted Reproductive Technologies Drugs Breakdown Data by Type

4.1 Global Assisted Reproductive Technologies Drugs Historic Market Size by Type (2020-2025)

4.2 Global Assisted Reproductive Technologies Drugs Forecasted Market Size by Type (2026-2031)

5 Assisted Reproductive Technologies Drugs Breakdown Data by Application

5.1 Global Assisted Reproductive Technologies Drugs Historic Market Size by Application (2020-2025)

5.2 Global Assisted Reproductive Technologies Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Assisted Reproductive Technologies Drugs Market Size (2020-2031)

6.2 North America Assisted Reproductive Technologies Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025)

6.4 North America Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Assisted Reproductive Technologies Drugs Market Size (2020-2031)

7.2 Europe Assisted Reproductive Technologies Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025)

7.4 Europe Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Assisted Reproductive Technologies Drugs Market Size (2020-2031)

8.2 Asia-Pacific Assisted Reproductive Technologies Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Assisted Reproductive Technologies Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Assisted Reproductive Technologies Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Assisted Reproductive Technologies Drugs Market Size (2020-2031)

9.2 Latin America Assisted Reproductive Technologies Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025)

9.4 Latin America Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Assisted Reproductive Technologies Drugs Market Size (2020-2031)

10.2 Middle East & Africa Assisted Reproductive Technologies Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck Serono

11.1.1 Merck Serono Company Details

11.1.2 Merck Serono Business Overview

11.1.3 Merck Serono Assisted Reproductive Technologies Drugs Introduction

11.1.4 Merck Serono Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.1.5 Merck Serono Recent Development

11.2 Ipsen

11.2.1 Ipsen Company Details

11.2.2 Ipsen Business Overview

11.2.3 Ipsen Assisted Reproductive Technologies Drugs Introduction

11.2.4 Ipsen Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.2.5 Ipsen Recent Development

11.3 Ferring

11.3.1 Ferring Company Details

11.3.2 Ferring Business Overview

11.3.3 Ferring Assisted Reproductive Technologies Drugs Introduction

11.3.4 Ferring Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.3.5 Ferring Recent Development

11.4 Organon

11.4.1 Organon Company Details

11.4.2 Organon Business Overview

11.4.3 Organon Assisted Reproductive Technologies Drugs Introduction

11.4.4 Organon Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.4.5 Organon Recent Development

11.5 Solvay

11.5.1 Solvay Company Details

11.5.2 Solvay Business Overview

11.5.3 Solvay Assisted Reproductive Technologies Drugs Introduction

11.5.4 Solvay Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.5.5 Solvay Recent Development

11.6 Besins

11.6.1 Besins Company Details

11.6.2 Besins Business Overview

11.6.3 Besins Assisted Reproductive Technologies Drugs Introduction

11.6.4 Besins Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.6.5 Besins Recent Development

11.7 Zhejiang Xianju

11.7.1 Zhejiang Xianju Company Details

11.7.2 Zhejiang Xianju Business Overview

11.7.3 Zhejiang Xianju Assisted Reproductive Technologies Drugs Introduction

11.7.4 Zhejiang Xianju Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.7.5 Zhejiang Xianju Recent Development

11.8 Changchun GeneScience

11.8.1 Changchun GeneScience Company Details

11.8.2 Changchun GeneScience Business Overview

11.8.3 Changchun GeneScience Assisted Reproductive Technologies Drugs Introduction

11.8.4 Changchun GeneScience Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.8.5 Changchun GeneScience Recent Development

11.9 Hybio Pharmaceutical

11.9.1 Hybio Pharmaceutical Company Details

11.9.2 Hybio Pharmaceutical Business Overview

11.9.3 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Introduction

11.9.4 Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.9.5 Hybio Pharmaceutical Recent Development

11.10 Livzon Pharmaceutical

11.10.1 Livzon Pharmaceutical Company Details

11.10.2 Livzon Pharmaceutical Business Overview

11.10.3 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Introduction

11.10.4 Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025)

11.10.5 Livzon Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ipsen S A

Ferring

Organon

Solvay S A

Zhejiang Xianju

Hybio Pharmaceutical

Livzon Pharmaceutical

Besins

Changchun GeneScience

Merck Serono

List of Tables

Table 1. Global Assisted Reproductive Technologies Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Down-Regulation Drugs

Table 3. Key Players of Ovulation Stimulation Drugs

Table 4. Key Players of Ovulation Inducing Drugs

Table 5. Key Players of Luteal Support Medications

Table 6. Global Assisted Reproductive Technologies Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Assisted Reproductive Technologies Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Assisted Reproductive Technologies Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Assisted Reproductive Technologies Drugs Market Share by Region (2020-2025)

Table 10. Global Assisted Reproductive Technologies Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Assisted Reproductive Technologies Drugs Market Share by Region (2026-2031)

Table 12. Assisted Reproductive Technologies Drugs Market Trends

Table 13. Assisted Reproductive Technologies Drugs Market Drivers

Table 14. Assisted Reproductive Technologies Drugs Market Challenges

Table 15. Assisted Reproductive Technologies Drugs Market Restraints

Table 16. Global Assisted Reproductive Technologies Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Assisted Reproductive Technologies Drugs Market Share by Players (2020-2025)

Table 18. Global Top Assisted Reproductive Technologies Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Drugs as of 2024)

Table 19. Ranking of Global Top Assisted Reproductive Technologies Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Assisted Reproductive Technologies Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Assisted Reproductive Technologies Drugs, Headquarters and Area Served

Table 22. Global Key Players of Assisted Reproductive Technologies Drugs, Product and Application

Table 23. Global Key Players of Assisted Reproductive Technologies Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Assisted Reproductive Technologies Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Assisted Reproductive Technologies Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Assisted Reproductive Technologies Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Assisted Reproductive Technologies Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Assisted Reproductive Technologies Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Assisted Reproductive Technologies Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Assisted Reproductive Technologies Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Assisted Reproductive Technologies Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Assisted Reproductive Technologies Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Assisted Reproductive Technologies Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Assisted Reproductive Technologies Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Assisted Reproductive Technologies Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Assisted Reproductive Technologies Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Assisted Reproductive Technologies Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Assisted Reproductive Technologies Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Assisted Reproductive Technologies Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Assisted Reproductive Technologies Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Merck Serono Company Details

Table 49. Merck Serono Business Overview

Table 50. Merck Serono Assisted Reproductive Technologies Drugs Product

Table 51. Merck Serono Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 52. Merck Serono Recent Development

Table 53. Ipsen Company Details

Table 54. Ipsen Business Overview

Table 55. Ipsen Assisted Reproductive Technologies Drugs Product

Table 56. Ipsen Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 57. Ipsen Recent Development

Table 58. Ferring Company Details

Table 59. Ferring Business Overview

Table 60. Ferring Assisted Reproductive Technologies Drugs Product

Table 61. Ferring Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 62. Ferring Recent Development

Table 63. Organon Company Details

Table 64. Organon Business Overview

Table 65. Organon Assisted Reproductive Technologies Drugs Product

Table 66. Organon Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 67. Organon Recent Development

Table 68. Solvay Company Details

Table 69. Solvay Business Overview

Table 70. Solvay Assisted Reproductive Technologies Drugs Product

Table 71. Solvay Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 72. Solvay Recent Development

Table 73. Besins Company Details

Table 74. Besins Business Overview

Table 75. Besins Assisted Reproductive Technologies Drugs Product

Table 76. Besins Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 77. Besins Recent Development

Table 78. Zhejiang Xianju Company Details

Table 79. Zhejiang Xianju Business Overview

Table 80. Zhejiang Xianju Assisted Reproductive Technologies Drugs Product

Table 81. Zhejiang Xianju Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 82. Zhejiang Xianju Recent Development

Table 83. Changchun GeneScience Company Details

Table 84. Changchun GeneScience Business Overview

Table 85. Changchun GeneScience Assisted Reproductive Technologies Drugs Product

Table 86. Changchun GeneScience Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 87. Changchun GeneScience Recent Development

Table 88. Hybio Pharmaceutical Company Details

Table 89. Hybio Pharmaceutical Business Overview

Table 90. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Product

Table 91. Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 92. Hybio Pharmaceutical Recent Development

Table 93. Livzon Pharmaceutical Company Details

Table 94. Livzon Pharmaceutical Business Overview

Table 95. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Product

Table 96. Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Drugs Business (2020-2025) & (US$ Million)

Table 97. Livzon Pharmaceutical Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Assisted Reproductive Technologies Drugs Picture

Figure 2. Global Assisted Reproductive Technologies Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Assisted Reproductive Technologies Drugs Market Share by Type: 2024 VS 2031

Figure 4. Down-Regulation Drugs Features

Figure 5. Ovulation Stimulation Drugs Features

Figure 6. Ovulation Inducing Drugs Features

Figure 7. Luteal Support Medications Features

Figure 8. Global Assisted Reproductive Technologies Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Assisted Reproductive Technologies Drugs Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacy Case Studies

Figure 11. Specialty & Retail Pharmacy Case Studies

Figure 12. Online Pharmacy Case Studies

Figure 13. Assisted Reproductive Technologies Drugs Report Years Considered

Figure 14. Global Assisted Reproductive Technologies Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Assisted Reproductive Technologies Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Assisted Reproductive Technologies Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Assisted Reproductive Technologies Drugs Market Share by Players in 2024

Figure 18. Global Top Assisted Reproductive Technologies Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Assisted Reproductive Technologies Drugs Revenue in 2024

Figure 20. North America Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Assisted Reproductive Technologies Drugs Market Share by Country (2020-2031)

Figure 22. United States Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Assisted Reproductive Technologies Drugs Market Share by Country (2020-2031)

Figure 26. Germany Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Assisted Reproductive Technologies Drugs Market Share by Region (2020-2031)

Figure 34. China Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Assisted Reproductive Technologies Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Assisted Reproductive Technologies Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Assisted Reproductive Technologies Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Merck Serono Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 50. Ipsen Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 51. Ferring Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 52. Organon Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 53. Solvay Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 54. Besins Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 55. Zhejiang Xianju Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 56. Changchun GeneScience Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 57. Hybio Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 58. Livzon Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Drugs Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Assistive Reproductive Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assistive Reproductive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Assisted Reproductive Apparatus Market Research Report 2025

Global Assisted Reproductive Treatment Market Research Report 2024

IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assisted Reproductive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Assisted Reproductive Medications Market Research Report 2024

Global Infertility Treatment Drugs Market Insights Forecast to 2030

Global Injectable Fertility Medications Market Research Report 2024

Global Fertility Enhancing Treatment Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Fertility Drugs Market Insights Forecast to 2030

Global Injectable IVF Medications Market Research Report 2024

Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global IVF Service Market Research Report 2024

Female Infertility Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IVF and ART Incubators Market Research Report 2024

Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Fertilization IVF Treatment Market

Global In vitro Fertilization IVF Incubators Market Insights Forecast to 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Z19487

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34B2983

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19V3238

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35F5845

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions